In particular, there is clinical evidence that overexpression and hyperphosphorylation of the extracellular-regulated protein kinase 5 (ERK5) are associated with overall poor survival rates of breast cancer patients and resistance to chemotherapy [4–7]. The gene discussed is MAPK7; the disease is breast carcinoma.